Investigation of differentially expressed genes and dysregulated pathways involved in multiple sclerosis
| Author | Udhaya Kumar, S. |
| Author | Datta, Ankur |
| Author | Gnanasambandan, Ramanathan |
| Author | Younes, Salma |
| Author | Medha, Tamma |
| Author | Siva, Ramamoorthy |
| Author | George Priya Doss, C. |
| Author | Zayed, Hatem |
| Available date | 2022-12-15T08:24:44Z |
| Publication Date | 2022 |
| Publication Name | Advances in Protein Chemistry and Structural Biology |
| Resource | Scopus |
| Abstract | Multiple Sclerosis (MS) is a neurodegenerative autoimmune and organ-specific demyelinating disorder, known to affect the central nervous system (CNS). While genetic studies have revealed several critical genes and diagnostic biomarkers associated with MS, the etiology of the disease remains poorly understood. This study is aimed at screening and identifying the key genes and canonical pathways associated with MS. Gene expression profiling of the microarray dataset GSE38010 was used to analyze two control brain samples (control 1; GSM931812, control 2; GSM931813), active inflammation stage samples (CAP1; GSM931815, CAP2; GSM931816) and late subsided stage samples (CP1; GSM931817, CP2; GSM931818) collected from patients ranging between 23 and 54 years and both genders. This analysis yielded a list of 58,866 DEGs (29,433 for active-inflammation stage and 29,433 for late-subsided Stage). The interactions between the DEGs were then studied using STRING, Cytoscape software, and MCODE was employed to find the genes that form clusters. Functional enrichment and integrative analysis were performed using ClueGO/CluePedia and MetaCore. Our data revealed dysregulated key canonical pathways in MS patients. In addition, we identified three hub genes (SCN2A, HTR2A, and HCN1) that may serve as potential biomarkers for the prognosis of MS. Furthermore, the expression patterns of HPCA and PLCB1 provide insights into the progressive stages of MS, indicating that these genes could be used in predicting MS progression. We were able to map potential biomarkers that could be used for the prognosis and diagnosis of MS. 2022 Elsevier Inc. |
| Sponsor | The authors would like to take this opportunity to thank the management of Vellore Institute of Technology (VIT), Vellore, India, and Qatar University, Doha, Qatar, for providing the necessary facilities and encouragement to carry out this work. UKS, HZ, and GPDC were involved in the study's design. UKS, AD, TM, SR, and GR were involved in the data collection and conducted the experiment. UKS, AD, SY, TM, SR, and GR were involved in the acquisition, analysis, and interpretation results. UKS and AD drafted the manuscript. GPDC and HZ supervised the entire study and were involved in the study design, the acquisition, analysis, and understanding of the data, and critically reviewed the manuscript. All authors edited and approved the submitted version of the article. The authors have declared that no conflicts of interest exist. |
| Language | en |
| Publisher | Elsevier |
| Subject | Active Inflammation Biomarkers Expression profiling data Functional enrichment MetaCore Multiple sclerosis Protein networks |
| Type | Book chapter |
| Pagination | 235-259 |
| Volume Number | 131 |
Check access options
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Biomedical Sciences [687 items ]